What is coming will likely be the most significant shift in the American banking landscape since the 2008 financial crisis. Bank earnings kick off Friday.
Continue readingCategory Archives: Uncategorized
Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know
Patients with early Alzheimer’s disease could still pay more than $5,000 in out-of-pocket costs for Leqembi even with Medicare coverage.
Continue readingBuy Buy Baby auction is canceled, but buyers are still interested in making a bid
Bed Bath & Beyond canceled an auction for its Buy Buy Baby business, but the chain could still end up being saved.
Continue readingSmall businesses may have a hard time finding teen workers this summer
The unemployment rate for teens aged 16 to 19 crept up slightly in June, while the labor participation rate fell year on year.
Continue readingSales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Analysts believe the Medicare registry requirement and new guidance on Leqembi’s prescription label could potentially weigh on sales in the near term.
Continue readingU.S. officials say risk of locally acquired malaria remains low as nationwide cases jump to seven
The CDC and health experts say the new locally acquired cases in Florida and Texas shouldn’t warrant panic about widespread malaria transmission in the U.S.
Continue readingEV sales: Hyundai overtakes GM, but Tesla’s U.S. dominance continues
Tesla, led by CEO Elon Musk, has grown its lead over the legacy automakers Hyundai and General Motors to roughly 300,000 vehicles.
Continue readingLevi Strauss shares drop after retailer slashes guidance on weak wholesale revenue
Levi slashed its profit outlook for the year after it reported a slowdown in US wholesale revenue that the retailer expects will continue.
Continue readingNikola falls short of winning shareholder support to issue new stock – but a new law may help
Nikola adjourned its annual meeting to try to win more votes to issue new stock. A potential legal change in Delaware may give it some […]
Continue readingFDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding.
Continue reading